Tate & Lyle Plc · LSE:TATE

Tate & Lyle — Shareholder Meeting (July 2017)

13 slides from Tate & Lyle's shareholder meeting presentation, Jul 27, 2017

  1. Slide 1: Annual General Meeting

    ANNUAL GENERAL MEETING 27 JULY 2017 Copyright © Tate & Lyle PLC 2017

  2. Slide 2: Dr Gerry Murphy, Chairman

    DR GERRY MURPHY Chairman 2

  3. Slide 3: Javed Ahmed, Chief Executive

    JAVED AHMED Chief Executive 3

  4. Slide 4: Year of strong progress and delivery

    Year of strong progress and delivery Commercial Operational Financial • Speciality Food Ingredients • Very good performance across • Strong cash generation performed well manufacturing network • Particularly strong year • Continued strengthening of • Balance sheet flexibility for Bulk Ingredients cu

  5. Slide 5: Financial Highlights

    Financial Highlights Year ended 31 March 2017 Sales Adjusted profit before tax Adjusted diluted EPS £2.8bn £271m 47.1p +2% +20% +16% Adjusted free cash flow Net debt Return on Capital Employed £174m £452m 14.3% +£121m up £18m +300bps Adjusted results and a number of other terms and performance measu

  6. Slide 6: Speciality Food Ingredients

    Speciality Food Ingredients Adjusted operating profit Adjusted operating margin £181m 18.2% +5%* +150bps • In core business, volume and operating profit both higher • North American volume lower driven by softer demand from some larger customers • Asia Pacific and Latin America continue to perform w

  7. Slide 7: Bulk Ingredients

    Bulk Ingredients Adjusted operating profit Adjusted operating margin £129m 7.3% +32% +150bps • Strong commercial execution and manufacturing performance • Improved margins supported by low input costs • Good sweetener demand and mix improvement • Relatively stable commodity markets See descriptions

  8. Slide 8: New Products: Continued momentum

    New Products: Continued momentum Sales growth from New Products (US$m)1 • Growth across all three platforms 200 • Expanding product families – Non-GMO Starches – CLARIA® Bliss2 105 43% – MULTIVANTAGE® Syrup CAGR 86 – Crystalline DOLCIA PRIMA® Allulose 69 • Enhanced stevia portfolio through 48 new ex

  9. Slide 9: Celebrating the new and the old

    Celebrating the new and the old Expanded customer-facing New Co-Generation facility Opening new lab in Mexico facilities, Germany Loudon, Tennessee and expanding lab in Singapore Koog, The Netherlands 150 Years 9

  10. Slide 10: Conclusion

    Conclusion Strong performance Clear priorities • Both business divisions performed well • Speciality Food Ingredients growth, including − North America volume • Good growth trajectory of New Products − Food Systems and in emerging markets • Steady earnings from core Bulk Ingredients • Excellent cash

  11. Slide 11: Questions

    QUESTIONS 11

  12. Slide 12: Resolutions

    RESOLUTIONS Resolution Resolution Resolution 1. Report and Accounts 9. Re-elect Lars Frederiksen 17. Authority to make political donations and incur political expenditure 2 Remuneration Policy 10 Re-elect Douglas Hurt 18. Authority to allot shares 3. Remuneration Report 11. Elect Jeanne Johns 19. Au

  13. Slide 13: Annual General Meeting

    ANNUAL GENERAL MEETING 27 JULY 2017 Copyright © Tate & Lyle PLC 2017

Tate & Lyle — Shareholder Meeting (July 2017) on 6ix